CPA
EXAS

Clear Perspective Advisors’s Exact Sciences EXAS Stock Holding History

Clear Perspective Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-300
Closed -$16K – 500
2017
Q4 		$16K Hold
300
– – 0.01% 307
2017
Q3 		$14K Sell
300
-900
-75% -$36.2K 0.01% 319
2017
Q2 		$42K Buy
+1,200
New +$37K 0.04% 237

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Clear Perspective Advisors's EXAS Position: Q1 2018 in Review

Clear Perspective Advisors sold out of Exact Sciences (EXAS) in Q1 2018, closing a stake of 300 shares — an estimated $16K sold.

Clear Perspective Advisors first reported a position in EXAS in Q2 2017 and held it in 3 quarters. The position peaked at $42K in Q2 2017. 319 funds tracked by Wall St. Rank hold EXAS as of Q1 2018.

  • Clear Perspective Advisors reported no remaining Exact Sciences position as of Q1 2018 after selling out during the quarter.
  • Clear Perspective Advisors sold 300 Exact Sciences shares in Q1 2018, an estimated $16K.
  • Clear Perspective Advisors first reported a position in Exact Sciences in Q2 2017 and held it in 3 quarters.
  • Clear Perspective Advisors's Exact Sciences position peaked at $42K in Q2 2017.
  • 319 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2018.

Based on Clear Perspective Advisors's 13F filing for Q1 2018, filed 14 May 2018.